EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ypsomed Holding AG's enterprise value is CHF4,656.3 Mil.
Ypsomed Holding AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was CHF158.7 Mil. Therefore, Ypsomed Holding AG's EV-to-EBITDA for today is 29.35.
The historical rank and industry rank for Ypsomed Holding AG's EV-to-EBITDA or its related term are showing as below:
XSWX:YPSN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.11 Med: 26.52 Max: 39.83
Current: 29.35
During the past 13 years, the highest EV-to-EBITDA of Ypsomed Holding AG was 39.83. The lowest was 12.11. And the median was 26.52.
XSWX:YPSN's EV-to-EBITDA is ranked worse than 76.95% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 16.29
vs XSWX:YPSN: 29.35
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Ypsomed Holding AG EV-to-EBITDA Historical Data
The historical data trend for Ypsomed Holding AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ypsomed Holding AG's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's EV-to-EBITDA falls into.
Ypsomed Holding AG's current Enterprise Value is CHF4,656.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was CHF158.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (XSWX:YPSN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ypsomed Holding AG's PE Ratio for today is calculated as:
Ypsomed Holding AG's share price for today is CHF331.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was CHF5.330.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Ypsomed Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Ypsomed Holding AG (XSWX:YPSN) Business Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:YPSN has been successfully added to your 